These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 3888381)

  • 1. Some aspects of size-dependent differential drug response in primary and metastatic tumors.
    Abe I; Suzuki M; Hori K; Saito S; Sato H
    Cancer Metastasis Rev; 1985; 4(1):27-39. PubMed ID: 3888381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transvascular drug delivery in solid tumors.
    Yuan F
    Semin Radiat Oncol; 1998 Jul; 8(3):164-75. PubMed ID: 9634493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of vascular normalization on interstitial flow and delivery of liposomes in tumors.
    Ozturk D; Yonucu S; Yilmaz D; Unlu MB
    Phys Med Biol; 2015 Feb; 60(4):1477-96. PubMed ID: 25611340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies.
    Poste G
    Cancer Treat Rep; 1986 Jan; 70(1):183-99. PubMed ID: 3510734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of the microcirculation in tumors.
    Suzuki M; Hori K; Abe I; Saito S; Sato H
    Cancer Metastasis Rev; 1984; 3(2):115-26. PubMed ID: 6567480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevating blood pressure as a strategy to increase tumor-targeted delivery of macromolecular drug SMANCS: cases of advanced solid tumors.
    Nagamitsu A; Greish K; Maeda H
    Jpn J Clin Oncol; 2009 Nov; 39(11):756-66. PubMed ID: 19596662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Functional characterization of microcirculation in tumors: chemotherapeutic implications].
    Suzuki M; Hori K; Abe I; Saito S
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):751-6. PubMed ID: 3985643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image-based spatio-temporal model of drug delivery in a heterogeneous vasculature of a solid tumor - Computational approach.
    Moradi Kashkooli F; Soltani M; Rezaeian M; Taatizadeh E; Hamedi MH
    Microvasc Res; 2019 May; 123():111-124. PubMed ID: 30711547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetically assisted intraperitoneal drug delivery for cancer chemotherapy.
    Shamsi M; Sedaghatkish A; Dejam M; Saghafian M; Mohammadi M; Sanati-Nezhad A
    Drug Deliv; 2018 Nov; 25(1):846-861. PubMed ID: 29589479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor heterogeneity and drug resistance.
    Dexter DL; Leith JT
    J Clin Oncol; 1986 Feb; 4(2):244-57. PubMed ID: 3944607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
    Maeda H; Bharate GY; Daruwalla J
    Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new drug delivery system in metastatic foci of cancer].
    Suzuki M; Hori K; Saito S; Tanda S; Li YL; Zhang QH; Abe I
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1219-22. PubMed ID: 2730021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers to drug delivery in interventional oncology.
    Sheth RA; Hesketh R; Kong DS; Wicky S; Oklu R
    J Vasc Interv Radiol; 2013 Aug; 24(8):1201-7. PubMed ID: 23735316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model.
    Jain RK; Tong RT; Munn LL
    Cancer Res; 2007 Mar; 67(6):2729-35. PubMed ID: 17363594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines.
    Greish K
    J Drug Target; 2007; 15(7-8):457-64. PubMed ID: 17671892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new approach to cancer chemotherapy: selective enhancement of tumor blood flow with angiotensin II.
    Suzuki M; Hori K; Abe I; Saito S; Sato H
    J Natl Cancer Inst; 1981 Sep; 67(3):663-9. PubMed ID: 6944536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity.
    Maeda H
    Adv Drug Deliv Rev; 2015 Aug; 91():3-6. PubMed ID: 25579058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.
    Leite de Oliveira R; Hamm A; Mazzone M
    Mol Aspects Med; 2011 Apr; 32(2):71-87. PubMed ID: 21540050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.